Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACCORA: Pemetrexed/Cisplatin + RT in NSCLC
NCT00497315Phase 2Completed
- Start
- Feb 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of pemetrexed in non-small cell lung cancer (NSCLC) (2 arms). Primary endpoint: Response Rate. Started Feb 2006; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00497315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00497315.